End-of-day quote
Other stock markets
|
||
- USD | - |
|
2022 | Gene Biotherapeutics, Inc. Auditor Raises 'Going Concern' Doubt | CI |
2021 | Gene Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020 | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 70 | 22/03/22 | |
James Grainer
CHM | Chairman | 69 | 22/20/22 |
Lois Chandler
COO | Chief Operating Officer | - | 01/10/01 |
Ronald Shebuski
CTO | Chief Tech/Sci/R&D Officer | 71 | 22/20/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 70 | 22/03/22 | |
James Grainer
CHM | Chairman | 69 | 22/20/22 |
Ronald Shebuski
CTO | Chief Tech/Sci/R&D Officer | 71 | 22/20/22 |
Kaushik Vyas
BRD | Director/Board Member | 68 | 22/20/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 64,931,888 | 60,931,888 ( 93.84 %) | 0 | 93.84 % |
Stock B | 0 | 498 | 0 | 0 |
Company contact information
Taxus Cardium Pharmaceuticals Group, Inc.
11230 Sorrento Valley Road Suite 220
92121, San Diego
+858 414 1477
http://www.genebiotherapeutics.com![address CARDIUM THRPTCS](https://cdn.zonebourse.com/static/address/57215.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+16.59% | 44.44B | |
-9.89% | 37.99B | |
+35.74% | 37.75B | |
+27.12% | 30.78B | |
-8.64% | 27.38B | |
+11.81% | 26.17B | |
+45.08% | 14.15B | |
+32.85% | 12.59B | |
-7.19% | 11.28B |
- Stock Market
- Equities
- CRXM Stock
- Stock
- Company CARDIUM THRPTCS